Investing Profile

Rémi Droller

InvestorVC
Managing Partner at Kurma Partners
kurmapartners.com/en/teamParis, France
Photo of Rémi Droller, Managing Partner at Kurma Partners
Your Intro Paths to Rémi Droller
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Rémi Droller on

cb
Current Investing Position
Kurma Partners Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
14

Rémi Droller is on these Sector & Stage Rankings

Rémi Droller's Investments On Record (4)

CompanyStageDateRound SizeTotal Raised
Vico Therapeutics
Series BJan 2024$72M
Series AJul 2020$31M
$120M
Co-investors: Amy Schulman (Polaris Partners), Jean-François Rivassou (Kurma Partners), Silvia Noiman (Pontifax Venture Capital), Felice Verduyn - van Weegen (EQT Life Sciences), Martijn Kleijwegt (EQT Life Sciences)
ImCheck Therapeutics
Series CJun 2022$100M
Series BDec 2019$53M
Series AMay 2017$22M
$180M
Co-investors: Klaus Breiner (Pureos Bioventures), Michael Baran (Pfizer Venture Investments), Dr. Regina Hodits (Wellington Partners), Raphael Wisniewski (Andera Partners), Florent Gros (Earlybird Venture Capital), Vincent Brichard
AM Pharma
Series UnknownMar 2020$25M
Series FJul 2019$130M
Series ESep 2014$16M
Series DSep 2011$40M
$210M
Co-investors: Joël Jean-Mairet (Ysios Capital), Laia Crespo (Sanofi Ventures), Martijn Kleijwegt (EQT Life Sciences), Felice Verduyn - van Weegen (EQT Life Sciences), Raphael Wisniewski (Andera Partners), Geert-Jan Mulder (Forbion)
Santen Pharmaceutical
Post Ipo EquitySep 2009$22M
Post Ipo EquityApr 2006$31M
Post Ipo EquitySep 2004$11M
Post Ipo EquityNov 2003$6M
Post Ipo EquityJan 2000$4M
$74M